We study variance estimation and associated confidence intervals for parameters characterizing genetic effects from genome-wide association studies (GWAS) in misspecified mixed model analysis. Previous studies have shown that, in spite of the model misspecification, certain quantities of genetic interests are consistently estimable, and consistent estimators of these quantities can be obtained using the restricted maximum likelihood (REML) method under a misspecified linear mixed model. However, the asymptotic variance of such a REML estimator is complicated and not ready to be implemented for practical use. In this paper, we develop practical and computationally convenient methods for estimating such asymptotic variances and constructing t...
markdownabstractOne of the goals of statistical genetics is to elucidate the genetic architecture of...
Genome-wide association studies (GWAS) are statistical tools widely used to identify the association...
With the advancements in DNA sequencing technology and the decreasing cost of sequencing, there has ...
We study behavior of the restricted maximum likelihood (REML) estimator under a misspecifie...
Abstract Background Genomic models that link phenotypes to dense genotype information are increasing...
In recent years, advanced technologies have enabled people to collect complex data and the analysis ...
Several methods have been proposed to estimate the variance in disease liability explained by large ...
Several methods have been proposed to estimate the variance in disease liability explained by large ...
In an Expectation-Maximization type Restricted Maximum Likelihood (REML) procedure, the estimation...
Several methods have been proposed to estimate the variance in disease liability explained by large ...
Several methods have been proposed to estimate the variance in disease liability explained by large ...
Several methods have been proposed to estimate the variance in disease liability explained by large ...
In genome-wide association studies (GWAS), penalization is an important approach for identifying gen...
Genome-wide association studies have been successful in uncovering novel genetic variants that are a...
This thesis develops and evaluates statistical methods for different types of genetic analyses, incl...
markdownabstractOne of the goals of statistical genetics is to elucidate the genetic architecture of...
Genome-wide association studies (GWAS) are statistical tools widely used to identify the association...
With the advancements in DNA sequencing technology and the decreasing cost of sequencing, there has ...
We study behavior of the restricted maximum likelihood (REML) estimator under a misspecifie...
Abstract Background Genomic models that link phenotypes to dense genotype information are increasing...
In recent years, advanced technologies have enabled people to collect complex data and the analysis ...
Several methods have been proposed to estimate the variance in disease liability explained by large ...
Several methods have been proposed to estimate the variance in disease liability explained by large ...
In an Expectation-Maximization type Restricted Maximum Likelihood (REML) procedure, the estimation...
Several methods have been proposed to estimate the variance in disease liability explained by large ...
Several methods have been proposed to estimate the variance in disease liability explained by large ...
Several methods have been proposed to estimate the variance in disease liability explained by large ...
In genome-wide association studies (GWAS), penalization is an important approach for identifying gen...
Genome-wide association studies have been successful in uncovering novel genetic variants that are a...
This thesis develops and evaluates statistical methods for different types of genetic analyses, incl...
markdownabstractOne of the goals of statistical genetics is to elucidate the genetic architecture of...
Genome-wide association studies (GWAS) are statistical tools widely used to identify the association...
With the advancements in DNA sequencing technology and the decreasing cost of sequencing, there has ...